MabionCD20® Compared to MabThera® in Patients With Rheumatoid Arthritis

计划入组 709 人 · 首次发布于 2015 年 6 月 11 日

MabionCD20 Compared to MabThera in Lymphoma Patients

计划入组 143 人 · 首次发布于 2015 年 12 月 1 日

MabionCD20® Compared to MabThera® and Rituxan® in Patients With Rheumatoid Arthritis

首次发布于 2020 年 12 月 23 日

Mabion-HER2_ADC(Mabion)

Omalizumab biosimilar (Mabion)

HDR-1903

Mabion SA

Poland

Abion Inc

Canada

HOECHST MARION ROUSSEL

United States

Mabion and NovalGen Partner to Advance Novel T-Cell Engager NVG-222 for Cancer Treatment

FDA Grants Type B Pre-IND Meeting for RTX-NP (MabionCD20) in Immune Thrombocytopenia

Maxion Therapeutics Strengthens Leadership with Appointment of Dr. Stefan Härtle as Chief Development Officer